Company profile
Solvonis Therapeutics
Transforming Treatment for Addiction and Mental Health Disorders
- Industry
- Biotechnology Research
- Employees
- 10
- Headquarters
- London
- Founded
- 2024
- Office locations
- 1
Solvonis Therapeutics company summary
Solvonis Therapeutics is a company in the Biotechnology Research industry, headquartered in London, founded in 2024. On LinkedIn the company has around 10 employees. Its listed specialties include Biotechnology, Clinical Stage, Alcohol Use Disorder, Addiction.
What technology does Solvonis Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Solvonis Therapeutics
Solvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing innovative medicines for addiction and mental health disorders. Headquartered in London and listed on the London Stock Exchange main market, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need. The company’s current focus is on Alcohol Use Disorder (AUD)—affecting over 40 million people across the U.S., UK, and EU4—and Post-Traumatic Stress Disorder (PTSD), which impacts more than 13 million adults in the U.S. and approximately 20 million across the same regions.
Specialties
Where is Solvonis Therapeutics located?
Solvonis Therapeutics lists 1 location.
Compare companies similar to Solvonis Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Solvonis Therapeutics solvonis.com | Biotechnology Research | 10 | 2024 | London |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Solvonis Therapeutics
What does Solvonis Therapeutics do?
Solvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing innovative medicines for addiction and mental health disorders. Headquartered in London and listed on the London Stock Exchange main market, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need. The company’s current focus is on Alcohol Use Disorder (AUD)—affecting over 40 million people across the U.S., UK, and EU4—and Post-Traumatic Stress Disorder (PTSD), which impacts more than 13 million adults in the U.S. and approximately 20 million across the same regions.
How many employees does Solvonis Therapeutics have?
Solvonis Therapeutics has around 10 employees on LinkedIn.
Where is Solvonis Therapeutics headquartered?
Solvonis Therapeutics is headquartered in London.
When was Solvonis Therapeutics founded?
Solvonis Therapeutics was founded in 2024.
Build a lead list from companies like Solvonis Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.